Integra Lifesciences Holdings Corp. 13F holders
Of the 44 funds followed here, 5 reported a position in Integra Lifesciences Holdings Corp. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 1.8 million shares worth $32.2 million, 0.0% of its reported book. New this quarter: Renaissance Technologies. Sold out: Citadel Advisors.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Geode Capital Management | 1,791,635 | $32.2 million | 0.0% | +134,650 | added | 30 June 2026 | 13F |
| Millennium Management | 1,439,747 | $25.9 million | 0.0% | +816,894 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 184,955 | $3.3 million | 0.0% | -27,755 | trimmed | 30 June 2026 | 13F |
| Renaissance Technologies | 10,500 | $188,580 | 0.0% | +10,500 | new | 30 June 2026 | 13F |
| FMR LLC | 5,141 | $92,326 | 0.0% | +265 | added | 30 June 2026 | 13F |
| Citadel Advisors | 0 | $0 | 0.0% | -476,701 | exited | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 13 August 2026 | 13G/A | Paradigm Capital Management Inc/Ny and 1 other | n/a | n/a | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 31 July 2026 | 13G | Vanguard Portfolio Management and 1 other | 3.9 million | 5.0% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 15 May 2026 | 13G | Paradigm Capital Management Inc/Ny and 1 other | 4.0 million | 5.2% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 27 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 17 February 2026 | 13G/A | Fuller & Thaler Asset Management, Inc. and 1 other | 3.6 million | 4.7% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 6 November 2025 | 13G/A | Invesco Ltd. and 1 other | 3.5 million | 4.5% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 8 September 2026 | 374 | $16.72 | SEC |
| 3 September 2026 | 1,832 | $16.81 | SEC |
| 10 August 2026 | 38,139 | $17.25 | SEC |
| 4 August 2026 | 40 | $17.88 | SEC |
| 3 August 2026 | 9,967 | $16.65 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 38,139 on 10 August 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to IART by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.